Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases

H Wang, X Lin, G Huang, R Zhou, S Lei, J Ren… - Acta Pharmacologica …, 2023 - nature.com
Aberrant NLRP3 activation has been implicated in the pathogenesis of numerous
inflammation-associated diseases. However, no small molecular inhibitor that directly …
被引用次数：11 相关文章

Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases.

HY Wang, X Lin, GG Huang, R Zhou, SY Lei… - Acta Pharmacologica …, 2023 - europepmc.org
Aberrant NLRP3 activation has been implicated in the pathogenesis of numerous
inflammation-associated diseases. However, no small molecular inhibitor that directly …

Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases

HY Wang, X Lin, GG Huang, R Zhou… - Acta …, 2023 - pubmed.ncbi.nlm.nih.gov
Aberrant NLRP3 activation has been implicated in the pathogenesis of numerous
inflammation-associated diseases. However, no small molecular inhibitor that directly …